The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Biz Plan Competition | Alive

Total Raised


Last Raised

$10K | 7 yrs ago

About Angio360 Diagnostics

Angio360 Diagnostics is developing cancer diagnostic products for animals and humans.

Angio360 Diagnostics Headquarter Location

Milwaukee, Wisconsin,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Angio360 Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Angio360 Diagnostics is included in 3 Expert Collections, including Medical Devices.


Medical Devices

8,298 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health IT

7,900 items

Latest Angio360 Diagnostics News

Milwaukee company among Neur Startup Challenge winners

May 22, 2015

By Kathleen Gallagher of the Journal Sentinel May 22, 2015 10:58 a.m. (0) Comments Angio360 Diagnostics LLC , a Milwaukee start-up formed in April that makes cancer diagnostic tools for veterinary and human applications, is among 13 winners of the Neuro Startup Challenge . The challenge helps bring promising medical inventions to market and is organized by the Heritage Provider Network in collaboration with the National Institutes of Health and the Center for Advancing Innovation . The winners were selected based on their business plans, financial models and live pitches. They will move into a third phase of the challenge, where they will launch their businesses, raise capital and negotiate licenses for their technology. Angio360 is aiming to provide a tool for early detection of brain tumors that uses a marker that detects new blood vessel formation. Stephanie Cossette , a Medical College of Wisconsin biochemist and molecular biologist, is president and chief executive officer of the company. © 2015 , Journal Sentinel Inc. All rights reserved. About Kathleen Gallagher

  • Where is Angio360 Diagnostics's headquarters?

    Angio360 Diagnostics's headquarters is located at Milwaukee.

  • What is Angio360 Diagnostics's latest funding round?

    Angio360 Diagnostics's latest funding round is Biz Plan Competition.

  • How much did Angio360 Diagnostics raise?

    Angio360 Diagnostics raised a total of $10K.

  • Who are the investors of Angio360 Diagnostics?

    Investors of Angio360 Diagnostics include Bridge to Cures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.